Gene Therapy
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT05903794
A Study of EXG102-031 in Patients With wAMD (Everest)
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 24, 2023
Completion: Feb 28, 2026
NCT06817343
A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)
Start: Sep 10, 2024
Completion: Feb 28, 2029
Loading map...